Sugiura Y, Sarukawa S, Hayasaka J, Kamochi H, Noguchi T, Mori Y
Department of Dentistry, Oral and Maxillofacial Surgery, Jichi Medical University, Tochigi, Japan.
Department of Plastic Surgery, Jichi Medical University, Tochigi, Japan.
Int J Oral Maxillofac Surg. 2018 Aug;47(8):983-989. doi: 10.1016/j.ijom.2018.02.009. Epub 2018 Mar 23.
The purpose of this study was to evaluate surgical outcomes in elderly patients who had undergone free fibula flap transfer for malignant head and neck tumours. A retrospective chart review was performed to identify patients who had undergone free fibula flap transfer for mandibular reconstruction after malignant tumour resection at Jichi Medical University Hospital between May 2009 and April 2015. Enrolled patients were divided into an elderly group (≥80years old) and a younger group (<80years old). Seventeen patients met the inclusion criteria and were included in the elderly group. Age at surgery ranged from 80 to 92years. Thirteen patients (76.5%) experienced postoperative complications. Surgical site complications occurred in seven patients. The success rate of free fibula flap transfer was 100%. Systemic complications occurred in nine patients, most commonly delirium (n=6). No perioperative mortality was encountered. The overall 1-year survival rate was 94.1% (16/17). No patient reported gait disturbance as a donor site complication or any other major complication. The incidence of postoperative complications did not differ significantly between the elderly and younger groups. Almost no difference in postoperative course was seen between the groups. Elderly patients appear to tolerate free fibula flap reconstruction just as well as younger patients.
本研究的目的是评估接受游离腓骨瓣移植治疗恶性头颈部肿瘤的老年患者的手术效果。进行了一项回顾性病历审查,以确定2009年5月至2015年4月期间在秩父医科大学医院因恶性肿瘤切除术后接受游离腓骨瓣移植进行下颌骨重建的患者。纳入的患者分为老年组(≥80岁)和年轻组(<80岁)。17名患者符合纳入标准并被纳入老年组。手术时年龄为80至92岁。13名患者(76.5%)出现术后并发症。7名患者发生手术部位并发症。游离腓骨瓣移植的成功率为100%。9名患者出现全身并发症,最常见的是谵妄(n = 6)。未发生围手术期死亡。总体1年生存率为94.1%(16/17)。没有患者报告供区并发症或任何其他主要并发症导致步态障碍。老年组和年轻组术后并发症的发生率没有显著差异。两组术后病程几乎没有差异。老年患者似乎与年轻患者一样能耐受游离腓骨瓣重建。